Suppr超能文献

血清抗p24抗体浓度对CD4淋巴细胞计数下降的预测价值高于酸解离p24抗原。

Serum anti-p24 antibody concentration has a predictive value on the decrease of CD4 lymphocyte count higher than acid-dissociated p24 antigen.

作者信息

Morand-Joubert L, Bludau H, Lerable J, Petit J C, Lefrère J J

机构信息

Service de Bacterio-Virologie, Hôpital Saint-Antoine, Paris, France.

出版信息

J Med Virol. 1995 Sep;47(1):87-91. doi: 10.1002/jmv.1890470116.

Abstract

We studied the prognostic value on the decrease of CD4 lymphocyte count of anti-p24 antibody (ab) titer and compared this value with that of polyclonal and monoclonal p24 (ag) titer before and after immune complex dissociation (ICD); 53 human immunodeficiency virus (HIV)-infected patients having CD4+ counts above 400/mm3 when first examined were followed up over a 3-year period including at least four visits; HIV disease progressors (n = 18) were defined as having CD4+ counts below 200/mm3 and non-progressors (n = 35) as having CD4+ counts still above 400/mm3 at the end of follow-up. Sera were collected at each visit and assayed for p24 ag with and without ICD and for anti-p24 ab titer. The mean anti-p24 ab titer of progressors and of non-progressors at entry was significantly different. A threshold of anti-p24 ab titer indicating a HIV progression was determined at 1/300. The proportion of individuals with an anti-p24 ab titer lower than 1/300 at least once during the study period was 34% in non-progressors and 94% in progressors. The difference between progressors and non-progressors at entry was significant with monoclonal p24 ag without ICD and more significant with monoclonal p24 ag after ICD. The marker having the highest predictive value was the anti-p24 ab titer, then monoclonal p24 ag with ICD, then polyclonal p24 ag with ICD. Anti-p24 ab is an earlier and stronger marker of the decrease of CD4 lymphocyte count than p24 ag even after ICD.

摘要

我们研究了抗 p24 抗体(ab)滴度降低对 CD4 淋巴细胞计数的预后价值,并将该价值与免疫复合物解离(ICD)前后多克隆和单克隆 p24(ag)滴度的预后价值进行比较;对 53 例初次检查时 CD4 + 计数高于 400/mm³ 的人类免疫缺陷病毒(HIV)感染患者进行了为期 3 年的随访,包括至少四次就诊;HIV 疾病进展者(n = 18)定义为随访结束时 CD4 + 计数低于 200/mm³,非进展者(n = 35)定义为随访结束时 CD4 + 计数仍高于 400/mm³。每次就诊时采集血清,检测有无 ICD 时的 p24 抗原以及抗 p24 抗体滴度。进展者和非进展者入院时的平均抗 p24 抗体滴度有显著差异。确定抗 p24 抗体滴度表明 HIV 进展的阈值为 1/300。在研究期间至少有一次抗 p24 抗体滴度低于 1/300 的个体比例,非进展者为 34%,进展者为 94%。入院时进展者和非进展者之间在未进行 ICD 的单克隆 p24 抗原方面差异显著,在进行 ICD 后的单克隆 p24 抗原方面差异更显著。预测价值最高的标志物是抗 p24 抗体滴度,其次是进行 ICD 的单克隆 p24 抗原,然后是进行 ICD 的多克隆 p24 抗原。即使在 ICD 后,抗 p24 抗体也是比 p24 抗原更早、更强的 CD4 淋巴细胞计数降低的标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验